Invasive Breast Cancer
Showing 1 - 25 of >10,000
Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT
Not yet recruiting
- Breast Cancer
- +2 more
- LS301-IT 0.025 mg/kg
- +3 more
-
Scottsdale, ArizonaIntegro Theranostics Research Site #1
Jun 2, 2023
Development of Multi-specific Antibodies Based on Immune
Not yet recruiting
- Invasive Breast Cancer
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Mar 2, 2023
Barriers Associated With Timely Adjuvant Chemotherapy
Active, not recruiting
- Invasive Breast Carcinoma
- Interview
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 25, 2022
Breast Cancer Trial in Salt Lake City (FNA and Core biopsy)
Completed
- Breast Cancer
- FNA and Core biopsy
-
Salt Lake City, UtahHuntsman Cancer Hospital
Oct 31, 2022
Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston
Completed
- Breast Cancer Stage IV
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 21, 2022
Microbiome on Breast Cancer Radiotherapy Toxicity
Recruiting
- DCIS
- Invasive Breast Cancer
- Stool sample
- Skin Swab Sample
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023
Infiltrating Duct Carcinoma of the Breast
Not yet recruiting
- Invasive Breast Cancer
- (no location specified)
Jan 28, 2023
Molecular Analysis of the Sloane Project
Enrolling by invitation
- DCIS
- +3 more
-
London, United KingdomKing's College London
May 11, 2023
Breast Cancer Trial in Chapel Hill (surgery, therapy, radiation therapy)
Active, not recruiting
- Breast Cancer
- surgery
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 20, 2022
Digital Breast Tomosynthesis to Improve Assessment of Resection
Completed
- Invasive Breast Cancer
- +2 more
-
Aarhus, Danmark, DenmarkDepartment og Plastic- and Breast Surgery
Feb 16, 2022
Tumor Biopsy in Creating Research Tissue Registry in
Recruiting
- Inflammatory Breast Carcinoma
- +2 more
- Biospecimen Collection
- +3 more
-
Houston, Texas
- +4 more
Jan 6, 2023
Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab
Not yet recruiting
- Invasive Breast Cancer
- +4 more
- Trastuzumab deruxtecan
- Durvalumab
-
Boston, Massachusetts
- +1 more
Mar 20, 2023
Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer Trial in Boston (Standard Genetic Counseling, Quantitative Genetic
Recruiting
- Breast Cancer
- +3 more
- Standard Genetic Counseling
- Quantitative Genetic Counseling
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 26, 2022
Invasive Breast Cancer, Ipsilateral Recurrence, Sentinel Lymph Node Biopsy Trial in France (Sentinel LN in breast cancer
Terminated
- Invasive Breast Cancer
- +2 more
- Sentinel LN in breast cancer recurrence
-
Bordeaux, France
- +8 more
Apr 19, 2022
Invasive Breast Cancer Trial in Madison ([18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging)
Recruiting
- Invasive Breast Cancer
- [18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging
-
Madison, WisconsinUniversity of Wisconsin, Madison
Dec 16, 2021
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,
Not yet recruiting
- HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
- SHR-A1811
- Trastuzumab Emtansine
- (no location specified)
Nov 7, 2023
Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)
Recruiting
- Breast Cancer
- +7 more
- Dendritic Cell Vaccine (DC1)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022
Breast Cancer Trial in Sioux Falls (Single Fraction IOeRT)
Active, not recruiting
- Breast Cancer
- Single Fraction IOeRT
-
Sioux Falls, South DakotaAvera Cancer Institute
Dec 22, 2021
Breast Cancer Trial in Tampa, Philadelphia (HER-2 pulsed Dendritic Cell Vaccine)
Active, not recruiting
- Breast Cancer
- HER-2 pulsed Dendritic Cell Vaccine
-
Tampa, Florida
- +1 more
Mar 23, 2022
Breast Cancer Stage I Trial (Microwave ablation)
Not yet recruiting
- Breast Cancer Stage I
- Microwave ablation
- (no location specified)
May 23, 2023